Mycota cream

Страна: Велика Британія

мова: англійська

Джерело: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активний інгредієнт:

Zinc undecenoate; Undecenoic acid

Доступна з:

Thornton & Ross Ltd

Код атс:

D01AE20

ІПН (Міжнародна Ім'я):

Zinc undecenoate; Undecenoic acid

Дозування:

200mg/1gram ; 50mg/1gram

Фармацевтична форма:

Cutaneous cream

Адміністрація маршрут:

Cutaneous

Клас:

No Controlled Drug Status

Тип рецепту:

Valid as a prescribable product

Огляд продуктів:

BNF: 13100200; GTIN: 5011309893014

інформаційний буклет

MYCOTA CREAM 25G

Характеристики продукта

OBJECT 1
MYCOTA CREAM
Summary of Product Characteristics Updated 08-Oct-2020 | Thornton &
Ross Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Mycota Cream
2. Qualitative and quantitative composition
Zinc Undecylenate Ph. Eur. 20.0% w/w
Undecylenic Acid Ph. Eur. 5.0% w/w
Excipient(s) with known effect:
Perfume Compound 11899 Narom (Contains Euganol) HSE 0.2% w/w
Emulsifying Wax (Contains Cetostearyl alcohol and Sodium
laurilsulfate) BP 15.0 % w/w
For full list of excipients, see section 6.1
3. Pharmaceutical form
Cream for topical administration
4. Clinical particulars
4.1 Therapeutic indications
For the treatment and prevention of athlete's foot
4.2 Posology and method of administration
ADULTS, CHILDREN AND ELDERLY
TREATMENT
Each night and morning wash thoroughly dry the foot, then smooth the
cream on to the affected area.
Take particular care to ensure the cream is massaged between the toes
then dust with Mycota Powder.
Wear clean socks or stockings each day dusted